Urinary collagen crosslink excretion: a better index of bone resorption than hydroxyproline in Paget's disease of bone?
- 31 July 1993
- journal article
- research article
- Published by Elsevier in Bone and Mineral
- Vol. 22 (1) , 1-8
- https://doi.org/10.1016/s0169-6009(08)80076-1
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Effect of menopause and hormone replacement therapy on urinary excretion of pyridinium cross‐links: a longitudinal and cross‐sectional studyClinical Endocrinology, 1992
- Evaluation of urinary hydroxypyridinium crosslink measurements as resorption markers in metabolic bone diseasesEuropean Journal of Clinical Investigation, 1991
- Urinary excretion of pyridinoline crosslinks correlates with bone turnover measured on iliac crest biopsy in patients with vertebral osteoporosisJournal of Bone and Mineral Research, 1991
- Application of an in vitro model and a clinical protocol in the assessment of the potency of a new bisphosphonateJournal of Bone and Mineral Research, 1989
- Urinary excretion of the hydroxypyridinium cross links of collagen in patients with rheumatoid arthritis.Annals of the Rheumatic Diseases, 1989
- Paget's disease of bone: early and late responses to three different modes of treatment with aminohydroxypropylidene bisphosphonate (APD).BMJ, 1987
- Pyridinium crosslinks of bone collagen and their location in peptides isolated from rat femurBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1987
- Efficacious Management with Aminobisphosphonate (APD) in Paget??s Disease of BoneClinical Orthopaedics and Related Research, 1987
- The Biosynthesis of Collagen and Its DisordersNew England Journal of Medicine, 1979
- The structure of pyridinoline, a collagen crosslinkBiochemical and Biophysical Research Communications, 1978